ΔNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report
Open Access
- 4 July 2017
- journal article
- research article
- Published by Springer Nature in Cellular Oncology
- Vol. 40 (6) , 631-638
Abstract
Purpose Multidrug resistance (MDR) is a major cause of treatment failure. In cancer cells, MDR is often caused by an increased efflux of therapeutic drugs mediated by an up-regulation of ATP binding cassette (ABC) transporters. It has previously been shown that oncogenic ΔNp73 plays an important role in chemo-resistance. Here we aimed at unraveling the role of ΔNp73 in regulating multidrug resistance in breast cancer and melanoma cells. Methods KEGG pathway analysis was used to identify pathways enriched in breast cancer samples with a high ΔNp73 expression. We found that the ABC transporter pathway was most enriched. The expression of selected ABC transporters was analyzed using qRT-PCR upon siRNA/shRNA-mediated knockdown or exogenous overexpression of ΔNp73 in the breast cancer-derived cell lines MCF7 and MDA-MB-231, as well as in primary melanoma samples and in the melanoma-derived cell line SK-MEL-28. The ability to efflux doxorubicin and the concomitant effects on cell proliferation were assessed using flow cytometry and WST-1 assays. Results We found that high ΔNp73 levels correlate with a general up-regulation of ABC transporters in breast cancer samples. In addition, we found that exogenous expression of ΔNp73 led to an increase in the expression of ABCB1 and ABCB5 in the breast cancer-derived cell lines tested, while knocking down of ΔNp73 resulted in a reduction in ABCB1 and ABCB5 expression. In addition, we found that ΔNp73 reduction leads to an intracellular retention of doxorubicin in MDA-MB-231 and MCF7 cells and a concomitant decrease in cell proliferation. The effect of ΔNp73 on ABCB5 expression was further confirmed in metastases from melanoma patients and in the melanoma-derived cell line SK-MEL-28. Conclusions Our data support a role for ΔNp73 in the multidrug-resistance of breast cancer and melanoma cells.Keywords
Funding Information
- Cancerfonden (CAN 2016/823, 150574)
- Knut och Alice Wallenbergs Stiftelse (KAW 2013.0093)
- Vetenskapsrådet (2016-02386)
- Radiumhemmets Forskningsfonder (144073)
- Stockholms Läns Landsting (Dnr LS 2015-1198)
This publication has 33 references indexed in Scilit:
- Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for ChemoresistanceJournal of Investigative Dermatology, 2012
- E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitryCell Cycle, 2012
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298The American Journal of Pathology, 2012
- Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing CellsPLOS ONE, 2012
- p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistanceBMC Cancer, 2010
- Isoform-specific p73 knockout mice reveal a novel role for ΔNp73 in the DNA damage response pathwayGenes & Development, 2010
- ABC transporters: the power to changeNature Reviews Molecular Cell Biology, 2009
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- Identification of cells initiating human melanomasNature, 2008
- ABCB5-Mediated Doxorubicin Transport and Chemoresistance in Human Malignant MelanomaCancer Research, 2005